Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sakura Tanaka

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Pediatric Surgery International|August 30, 2008
Clinical implications of a slight increase in the gene dosage of MYCN in neuroblastoma determined using quantitative PCRRyota Souzaki, Tatsuro Tajiri, Mayumi Higashi, et al.
European Journal of Pediatric Surgery : Official Journal of Austrian Association of Pediatric Surgery ... [Et Al] = Zeitschrift Fur Kinderchirurgie|October 27, 2014
Glypican 3 expression in pediatric malignant solid tumorsYoshiaki Kinoshita, Sakura Tanaka, Ryota Souzaki, et al.
Journal of Pediatric Surgery|December 17, 2009
Risks and benefits of ending of mass screening for neuroblastoma at 6 months of age in JapanTatsuro Tajiri, Ryota Souzaki, Yoshiaki Kinoshita, et al.
Journal of Pediatric Surgery|December 7, 2010
Hedgehog signaling pathway in neuroblastoma differentiationRyota Souzaki, Tatsuro Tajiri, Masae Souzaki, et al.
Pediatric Surgery International|July 16, 2010
Successful treatment of advanced pancreatoblastoma by a pylorus-preserving pancreatoduodenectomy after radiation and high-dose chemotherapyRyota Souzaki, Tatsuro Tajiri, Yoshiaki Kinoshita, et al.
Vaccine|August 29, 2009
Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2Xuefeng Duan, Yoshikazu Yonemitsu, Bin Chou, et al.
Biochemical and Biophysical Research Communications|August 7, 2007
In vivo repopulation of cytoplasmically gene transferred hematopoietic cells by temperature-sensitive mutant of recombinant Sendai viral vectorKumi Yoshida, Yoshikazu Yonemitsu, Sakura Tanaka, et al.
The Journal of Gene Medicine|December 13, 2007
Newly-developed Sendai virus vector for retinal gene transfer: reduction of innate immune response via deletion of all envelope-related genesYusuke Murakami, Yasuhiro Ikeda, Yoshikazu Yonemitsu, et al.
Molecular Cancer Therapeutics|January 7, 2011
Antagonism of VEGF by genetically engineered dendritic cells is essential to induce antitumor immunity against malignant ascitesMasahiko Sugiyama, Yoshihiro Kakeji, Shunichi Tsujitani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 2009
Sustained and NK/CD4+ T cell-dependent efficient prevention of lung metastasis induced by dendritic cells harboring recombinant Sendai virusAtsushi Komaru, Yasuji Ueda, Aki Furuya, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Pediatric Surgery International|August 30, 2008
Clinical implications of a slight increase in the gene dosage of MYCN in neuroblastoma determined using quantitative PCRRyota Souzaki, Tatsuro Tajiri, Mayumi Higashi, et al.
European Journal of Pediatric Surgery : Official Journal of Austrian Association of Pediatric Surgery ... [Et Al] = Zeitschrift Fur Kinderchirurgie|October 27, 2014
Glypican 3 expression in pediatric malignant solid tumorsYoshiaki Kinoshita, Sakura Tanaka, Ryota Souzaki, et al.
Journal of Pediatric Surgery|December 17, 2009
Risks and benefits of ending of mass screening for neuroblastoma at 6 months of age in JapanTatsuro Tajiri, Ryota Souzaki, Yoshiaki Kinoshita, et al.
Journal of Pediatric Surgery|December 7, 2010
Hedgehog signaling pathway in neuroblastoma differentiationRyota Souzaki, Tatsuro Tajiri, Masae Souzaki, et al.
Pediatric Surgery International|July 16, 2010
Successful treatment of advanced pancreatoblastoma by a pylorus-preserving pancreatoduodenectomy after radiation and high-dose chemotherapyRyota Souzaki, Tatsuro Tajiri, Yoshiaki Kinoshita, et al.
Vaccine|August 29, 2009
Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2Xuefeng Duan, Yoshikazu Yonemitsu, Bin Chou, et al.
Biochemical and Biophysical Research Communications|August 7, 2007
In vivo repopulation of cytoplasmically gene transferred hematopoietic cells by temperature-sensitive mutant of recombinant Sendai viral vectorKumi Yoshida, Yoshikazu Yonemitsu, Sakura Tanaka, et al.
The Journal of Gene Medicine|December 13, 2007
Newly-developed Sendai virus vector for retinal gene transfer: reduction of innate immune response via deletion of all envelope-related genesYusuke Murakami, Yasuhiro Ikeda, Yoshikazu Yonemitsu, et al.
Molecular Cancer Therapeutics|January 7, 2011
Antagonism of VEGF by genetically engineered dendritic cells is essential to induce antitumor immunity against malignant ascitesMasahiko Sugiyama, Yoshihiro Kakeji, Shunichi Tsujitani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 2009
Sustained and NK/CD4+ T cell-dependent efficient prevention of lung metastasis induced by dendritic cells harboring recombinant Sendai virusAtsushi Komaru, Yasuji Ueda, Aki Furuya, et al.
Pageof 3